COMPEERS: A cluster randomised feasibility study of COntingency Management and PEER Support to promote attendance, increase treatment engagement, and improve outcomes for people with dual diagnoses of psychosis and drug/alcohol problems (DDp)

South London and Maudsley NHS Foundation Trust0 个研究点目标入组 80 人开始时间: 2024年7月5日最近更新: 2024年7月15日

适应症

试验速览

暂无简介。

•1.Are aged 18 and over at enrolment
•2.Are receiving care from a participating CMHT
•3.Have a dual diagnosis of symptoms of both psychosis/schizophrenia spectrum diagnosis and drugs/alcohol problems (both ascertained according to the treating team's working diagnoses, which will be recorded on the clinical record)
•4.Are able to give informed consent and safely participate (i.e. severity of psychosis, drug/alcohol problems, and/or other problems does not, in the clinical judgement of the treating team, preclude consenting and safely participating)

•All participants receiving care from participating teams, with the target difficulties, judged by the team able to give informed consent and participate safely will be included. We will exclude only those participants whose care team deems their participation in the study unsafe, or considers them unable to give informed consent. This is likely to be because of the severity of their difficulties with psychosis or drug/alcohol problems.

发起方